Press Releases

Opthea Chairman's Address to the 2021 Annual General Meeting

October 19, 2021

Read More

Opthea Opens Patient Recruitment in Europe for Pivotal Phase 3 ShORe and COAST Wet AMD Trials of OPT-302

October 4, 2021

Read More

Opthea To Present at September 2021 Investor Conferences

September 2, 2021

Read More

Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights

August 30, 2021

Read More

Opthea To Present at the H.C. Wainwright Ophthalmology Virtual Conference

August 10, 2021

Read More

Opthea Expands Global Phase 3 ShORe and COAST Wet AMD Trials of OPT-302 into Canada

August 9, 2021

Read More

Opthea’s OPT-302 Granted FDA Fast Track Designation for Wet Age-Related Macular Degeneration

July 6, 2021

Read More

Opthea Appoints Company Secretary and Vice President of Finance

June 14, 2021

Read More

Opthea Appoints Julia A. Haller, MD, and Judith Robertson to Board of Directors

June 1, 2021

Read More

Opthea Company Secretary Resignation

April 6, 2021

Read More